基本信息
-
利拉鲁肽
-
204656-20-2
-
利拉鲁肽;利拉鲁肽/醋酸利拉鲁肽
-
C172H265N43O51
-
0
-
Liraglutide
-
-
-
Liraglutide;Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];Liraglutidum;Liraglutidum [inn-latin];N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
-
-
>182°C (dec.)
-
-
详细信息
适应症:用于成人2型糖尿病患者控制血糖。适用于单用二甲双胍或磺脲类药物大可耐受剂量后血糖仍控制不佳的患者,与二甲双胍或磺脲类药物联合应用。